Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Drug expenditure of high-cost patients and their characteristics in Finland.
Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications.
Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions.
Contemporary treatment options for relapsing-remitting multiple sclerosis.
Adult-onset vanishing white matter disease as differential diagnosis of primary progressive multiple sclerosis: A case report.
Orientational ordering of carotenoids in myelin membranes resolved by polarized Raman microspectroscopy.
Quality of life reporting in multiple sclerosis clinical trials: enough quality?
Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): rationale, design, and methodology.
TNFRSF1A polymorphisms and MS: Statistical signals transform into pathogenetic mechanisms.
Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.
Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects.
The incidence and prevalence of multiple sclerosis in nova scotia, Canada.
Autoimmune disease: A role for new anti-viral therapies?
Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study.
Alternative Approaches: A Systematic Review of Non-Pharmacological Treatments for Non-Spastic and Non-Trigeminal Pain in Patients with Multiple Sclerosis.
Gender and Uveitis in Patients with Multiple Sclerosis.
Correlation of midkine serum level with pro- and anti-inflamatory cytokines in multiple sclerosis.
Heavy metals, organic solvents and multiple sclerosis: an exploratory look at gene-environment interactions.
Grey matter damage in progressive multiple sclerosis versus amyotrophic lateral sclerosis: a voxel-based morphometry MRI study.
Superior temporal gyrus thickness correlates with cognitive performance in multiple sclerosis.
A simple score for estimating the long-term risk of fracture in patients with multiple sclerosis.
Social disruption alters pain and cognition in an animal model of multiple sclerosis.
Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis.
Accurately diagnosing and comprehensively managing MS.
Commercially available accelerometry as an ecologically valid measure of ambulation in individuals with multiple sclerosis.

Pages